Chinese Biotech Surpasses AI in Emerging-Market Growth Trade

Chinese biotech is becoming the leading growth trade in emerging markets, overtaking artificial intelligence. This shift highlights a changing investment landscape where biotech firms are expected to deliver higher returns. The shift is reflected in increasing investments toward Chinese biotech entities, emphasizing their competitive advancement. This change in focus could present potential opportunities for investors looking for growth in these sectors.